These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 793123)

  • 21. [Stomach ulcer. Physiologenetic aspects and therapy with special reference to carbenoxolone].
    Bianchi Porro G; Petrillo M
    Recenti Prog Med; 1976 Jul; 62(1):23-45. PubMed ID: 1037032
    [No Abstract]   [Full Text] [Related]  

  • 22. Carbenoxolone induced hypokalemia and ventricular tachycardia--report of a case.
    Lin CS; Wang SS
    Taiwan Yi Xue Hui Za Zhi; 1978 Apr; 77(4):418-22. PubMed ID: 276575
    [No Abstract]   [Full Text] [Related]  

  • 23. Carbenoxolone sodium: its role in ulcer healing.
    Langman MJ
    Drugs; 1976; 11(4):241-4. PubMed ID: 947739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbenoxolone-induced hypokalaemia simulating Guillain-Barré syndrome.
    Royston A; Prout BJ
    Br Med J; 1976 Jul; 2(6028):150-1. PubMed ID: 1276838
    [No Abstract]   [Full Text] [Related]  

  • 25. Comments on the effects of carbenozolone and trimipramine on peptic ulcer healing.
    Myren J; Berstad A
    Scand J Gastroenterol Suppl; 1976; 42():159-61. PubMed ID: 796969
    [No Abstract]   [Full Text] [Related]  

  • 26. Carbenoxolone-induced ascites.
    Robinson TJ
    Br J Clin Pract; 1977 Dec; 31(12):219, 221. PubMed ID: 607974
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative studies of the treatment of stomach ulcer with carbenoxolone].
    Van Camp F; Standaert L
    Tijdschr Gastroenterol; 1974; 17(1):51-63. PubMed ID: 4460265
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled double blind trial of carbenoxolone in gastric and duodenal ulcer.
    Hadzić N; Vrhovac B; Kallai L
    Int J Clin Pharmacol; 1974 Dec; 10(4):309-18. PubMed ID: 4613674
    [No Abstract]   [Full Text] [Related]  

  • 29. [Collateral effects of anti-ulcer therapy with carbenoxolone. General considerations. A clinical case].
    Frabetti F; Zardi V; Grappa P; Dattola L; Bellodi G
    Clin Ter; 1986 Jun; 117(6):455-62. PubMed ID: 3742966
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of gastric and duodenal ulcers using carbenoxolone sodium. (Double blind trial)].
    Hampel KE; Billich C; Dannenmeier HD; Fintelmann V; Fischer R; Schmid E; Treske U; Walz A
    Munch Med Wochenschr; 1972 May; 114(19):925-9. PubMed ID: 4559199
    [No Abstract]   [Full Text] [Related]  

  • 31. Rhabdomyolysis and acute tubular necrosis associated with carbenoxolone and diuretic treatment.
    Descamps C; Vandenbroucke JM; van Ypersele de Strihou C
    Br Med J; 1977 Jan; 1(6056):272. PubMed ID: 837068
    [No Abstract]   [Full Text] [Related]  

  • 32. Carbenoxolone sodium capsules in the treatment of duodenal ulcer. An endoscopic controlled trial.
    Gut; 1977 Sep; 18(9):717-20. PubMed ID: 342359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial.
    Cook PJ; Vincent-Brown A; Lewis SI; Perks S; Jewell DP; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():93-101. PubMed ID: 7010531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C
    Clin Ter; 1979 Mar; 88(6):605-19. PubMed ID: 157245
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.
    Giorgi-Conciato M; Daniotti S; Ferrari PA; Gaetani M; Petrin G; Sala P; Valentini P
    Scand J Gastroenterol Suppl; 1982; 81():1-41. PubMed ID: 6221398
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC; Molinari F; Barocci S
    Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum carbenoxolone in patients with gastric and duodenal ulcer: Absorption, efficacy and side-effects.
    Baron JH; Gribble JN; Rhodes C; Wright PA
    Gut; 1978 Apr; 19(4):330-5. PubMed ID: 648939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastric emptying in dyspeptic syndromes during treatment with a combination of carbenoxolone and metoclopramide, studied with a meal labeled with 99mTc colloidal sulfate].
    Sciarretta G; Turba E; Verri A; Pinetti P; Malaguti P
    Clin Ter; 1980 Jun; 93(6):639-48. PubMed ID: 7428319
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of ulcers with pirenzepin. Results from clinic and practice].
    Krempler F; Sandhofer F; Kalk A
    Wien Med Wochenschr; 1982 Sep; 132(18):427-32. PubMed ID: 6760563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrolyte status in duogastrone--treated duodenal ulcer patients.
    Odutola TA; Oladapo JM; Falaiye JM
    Niger Med J; 1978 Jul; 8(4):337-9. PubMed ID: 726667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.